Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Extracellular vesicles released from hiPSC-derived MSCs attenuate chronic prostatitis/chronic pelvic pain syndrome in rats by immunoregulation

Fig. 1

Identification of iMSCs and iMSCs-EVs. a Flow cytometric analysis demonstrated that iMSCs strongly expressed characteristic surface markers including CD44, CD73, CD90, and CD105, but not CD11b, CD19, CD34, CD45, and HLA-DR-. b The morphology of iMSCs. c The adipogenic differentiation of iMSCs. d The osteogenic differentiation of iMSCs. e Morphology of iMSCs-EVs under TEM. f The particle size distribution of iMSCs-EVs analyzed by Flow nano-analyzer. g Western blotting analysis showed that iMSCs-EVs positively expressed the specific markers CD63, Alix, and Tsg101, while the cis-Golgi matrix protein GM130 was negative

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512